ATE150466T1 - Neue 19-nor-steroide mit einer 11-beta- phenoxysulfonamid- oder 11-beta- phenoxysulfonylurea-gruppe, verfahren und zwischenprodukte zu ihrer herstellung sowie medikamenten und pharmazeutische präparate davon - Google Patents

Neue 19-nor-steroide mit einer 11-beta- phenoxysulfonamid- oder 11-beta- phenoxysulfonylurea-gruppe, verfahren und zwischenprodukte zu ihrer herstellung sowie medikamenten und pharmazeutische präparate davon

Info

Publication number: ATE150466T1
Authority: AT; Austria
Prior art keywords: radical; beta; alkyl; phenoxysulfonylurea; phenoxysulfonamide
Prior art date: 1993-06-17

Application number

AT94401344T

Other languages

English (en)

Inventor

Francois Nique

Jean-Georges Teutsch

De Velde Patrick Van

Original Assignee

Roussel Uclaf

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-06-17

Filing date

1994-06-16

Publication date

1997-04-15

1994-06-16 Application filed by Roussel Uclaf filed Critical Roussel Uclaf

1997-04-15 Application granted granted Critical

1997-04-15 Publication of ATE150466T1 publication Critical patent/ATE150466T1/de

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AT94401344T 1993-06-17 1994-06-16 Neue 19-nor-steroide mit einer 11-beta- phenoxysulfonamid- oder 11-beta- phenoxysulfonylurea-gruppe, verfahren und zwischenprodukte zu ihrer herstellung sowie medikamenten und pharmazeutische präparate davon ATE150466T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9307310A FR2706454B1 (fr)	1993-06-17	1993-06-17	Nouveaux 19-Nor stéroïdes, procédé et intermédiaires de préparation, application comme médicaments et compositions pharmaceutiques les contenant.

Publications (1)

Publication Number	Publication Date
ATE150466T1 true ATE150466T1 (de)	1997-04-15

Family

ID=9448234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94401344T ATE150466T1 (de)	1993-06-17	1994-06-16	Neue 19-nor-steroide mit einer 11-beta- phenoxysulfonamid- oder 11-beta- phenoxysulfonylurea-gruppe, verfahren und zwischenprodukte zu ihrer herstellung sowie medikamenten und pharmazeutische präparate davon

Country Status (16)

Country	Link
US (3)	US5494907A (de)
EP (1)	EP0629635B1 (de)
JP (1)	JP3621132B2 (de)
KR (1)	KR100341427B1 (de)
CN (2)	CN1054856C (de)
AT (1)	ATE150466T1 (de)
AU (1)	AU673919B2 (de)
CA (1)	CA2126158A1 (de)
DE (1)	DE69402114T2 (de)
DK (1)	DK0629635T3 (de)
ES (1)	ES2099551T3 (de)
FR (1)	FR2706454B1 (de)
GR (1)	GR3023107T3 (de)
HU (1)	HUT67308A (de)
RU (1)	RU2140423C1 (de)
ZA (1)	ZA943381B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE180669T1 (de) *	1993-03-05	1999-06-15	Akzo Nobel Nv	Verwendung von pregnanderivaten zur behandlung von tumoren
US5679788A (en) *	1993-06-17	1997-10-21	Roussel Uclaf	11 beta-substituted-19 nor-steroids
ATE473759T1 (de)	1998-05-22	2010-07-15	Univ Leland Stanford Junior	Bifunktionelle moleküle sowie darauf basierende therapien.
EP2147679B1 (de)	2001-07-25	2014-06-25	Raptor Pharmaceutical, Inc.	Zusammensetzungen für den Blut-Hirn-Schrankentransport
US7009052B2 (en) *	2003-03-20	2006-03-07	Warner Lambert Company Llc	Sulfonamide derivatives
CN100545158C (zh) *	2003-10-14	2009-09-30	科学和工业研究理事会	具有雌激素活性的(3r,4r)-反-3,4-二芳基苯并二氢吡喃衍生物
US7674784B2 (en) *	2004-09-29	2010-03-09	Morinaga Milk Industry Co., Ltd.	Drug and food or drink for improving hyperglycemia
EP2392258B1 (de)	2005-04-28	2014-10-08	Proteus Digital Health, Inc.	Pharma-Informatiksystem
CN101102777B (zh) *	2005-05-17	2011-07-06	森永乳业株式会社	用于改善胰脏功能的药物、食物或饮料
KR100866274B1 (ko) *	2005-05-17	2008-11-03	모리나가 뉴교 가부시키가이샤	췌장 기능 개선을 위한 의약 또는 음식품
GB0511051D0 (en) *	2005-05-31	2005-07-06	Exxonmobil Chem Patents Inc	Molecular sieve catalyst treatment
US7312198B2 (en) *	2005-07-12	2007-12-25	Essential Skincare, Llc	Protein compositions for promoting wound healing and skin regeneration
US9062126B2 (en)	2005-09-16	2015-06-23	Raptor Pharmaceuticals Inc.	Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
US8093233B2 (en) *	2005-09-22	2012-01-10	Morinaga Milk Industry Co., Ltd.	Agent for inhibiting visceral fat accumulation
PL3395372T3 (pl)	2009-02-20	2022-07-25	EnhanX Biopharm Inc.	Układ do dostarczania leków na bazie glutationu
CN102458374A (zh)	2009-05-06	2012-05-16	实验室护肤股份有限公司	包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
CN114957367B (zh) *	2022-05-27	2023-12-29	黄冈人福药业有限责任公司	一种生物法制备睾酮的精制方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR384842A (fr) *	1907-12-09	1908-04-23	Emile Artigue	Plaque photographique auto-retouche
FR471612A (fr) *	1913-05-08	1914-11-05	Zeiss Carl Soc	Lentille collectrice devant etre intercalée entre deux systèmes redresseurs dans les instruments destinés à l'inspection des corps creux
FR2528434B1 (fr) *	1982-06-11	1985-07-19	Roussel Uclaf	Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
US4978657A (en) *	1981-01-09	1990-12-18	Roussel Uclaf	Novel 11β-substituted-19-nor-steroids
FR2640977A2 (en) *	1982-06-11	1990-06-29	Roussel Uclaf	New position-11 substituted 19-norsteroids and their application as medicinal products.
EP0116974B1 (de) *	1983-02-18	1986-10-29	Schering Aktiengesellschaft	11-Beta-Aryl-Estradiene, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
FR2618783B1 (fr) *	1987-07-30	1991-02-01	Roussel Uclaf	Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
DE3820948A1 (de) *	1988-06-16	1989-12-21	Schering Ag	10ss, 11ss-ueberbrueckte steroide
JPH02188599A (ja) *	1988-11-16	1990-07-24	Roussel Uclaf	３―ケト―デルタ―４，９―１９―ノルステロイドから誘導される新物質及びそれらよりなる薬剤
US4970205A (en) *	1988-12-23	1990-11-13	Smithkline Beecham Corporation	Sulfonic acid substituted aromatic steroids as inhibitors of steroid 5-α-reductase
FR2643638B1 (fr) *	1989-02-24	1991-06-14	Roussel Uclaf	Nouveaux 19-nor steroides ayant en position 11beta une chaine carbonee comportant une fonction amide ou carbamate, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
DE69128820T2 (de) *	1990-08-14	1998-06-10	Hoechst Marion Roussel Inc	Neue 19-Nor Steroide, die eine Amid tragende Gruppe in der 11-Beta-Stelle haben, ihre Herstellung, ihre Verwendung als Medikamente und pharmazeutische Präparate davon
FR2685332A1 (fr) *	1991-12-20	1993-06-25	Roussel Uclaf	Nouveaux 19-nor sterouides ayant en position 11beta une chaine thiocarbonee, leur procede de preparation et les intermediaires et leur application a titre de medicaments.
FR2688004A1 (fr) *	1992-02-27	1993-09-03	Roussel Uclaf	Nouveaux sterouides comportant en position 17 un radical methylene lactone, leur procede et des intermediaires de preparation, leur application comme medicaments.

1993
- 1993-06-17 FR FR9307310A patent/FR2706454B1/fr not_active Expired - Fee Related
1994
- 1994-05-06 HU HU9401427A patent/HUT67308A/hu unknown
- 1994-05-17 ZA ZA943381A patent/ZA943381B/xx unknown
- 1994-05-19 US US08/246,190 patent/US5494907A/en not_active Expired - Lifetime
- 1994-06-16 DE DE69402114T patent/DE69402114T2/de not_active Expired - Lifetime
- 1994-06-16 RU RU94022277A patent/RU2140423C1/ru not_active IP Right Cessation
- 1994-06-16 KR KR1019940013594A patent/KR100341427B1/ko not_active Expired - Fee Related
- 1994-06-16 JP JP15640794A patent/JP3621132B2/ja not_active Expired - Fee Related
- 1994-06-16 CN CN94106469A patent/CN1054856C/zh not_active Expired - Fee Related
- 1994-06-16 EP EP94401344A patent/EP0629635B1/de not_active Expired - Lifetime
- 1994-06-16 ES ES94401344T patent/ES2099551T3/es not_active Expired - Lifetime
- 1994-06-16 DK DK94401344.0T patent/DK0629635T3/da active
- 1994-06-16 AT AT94401344T patent/ATE150466T1/de not_active IP Right Cessation
- 1994-06-17 CA CA002126158A patent/CA2126158A1/fr not_active Abandoned
- 1994-06-17 AU AU64763/94A patent/AU673919B2/en not_active Ceased
1995
- 1995-05-19 US US08/445,385 patent/US5556845A/en not_active Expired - Lifetime
- 1995-08-08 US US08/512,284 patent/US5705494A/en not_active Expired - Lifetime
1997
- 1997-04-11 GR GR960402896T patent/GR3023107T3/el unknown
1998
- 1998-05-09 CN CN98108945A patent/CN1271734A/zh active Pending

Also Published As

Publication number	Publication date
CN1101915A (zh)	1995-04-26
CN1271734A (zh)	2000-11-01
US5494907A (en)	1996-02-27
EP0629635B1 (de)	1997-03-19
US5705494A (en)	1998-01-06
US5556845A (en)	1996-09-17
ES2099551T3 (es)	1997-05-16
AU673919B2 (en)	1996-11-28
CA2126158A1 (fr)	1994-12-18
EP0629635A1 (de)	1994-12-21
KR950000729A (ko)	1995-01-03
HUT67308A (en)	1995-03-28
CN1054856C (zh)	2000-07-26
FR2706454A1 (fr)	1994-12-23
JP3621132B2 (ja)	2005-02-16
AU6476394A (en)	1994-12-22
DE69402114T2 (de)	1997-09-11
JPH0717996A (ja)	1995-01-20
DE69402114D1 (de)	1997-04-24
RU94022277A (ru)	1996-04-20
DK0629635T3 (da)	1997-09-22
GR3023107T3 (en)	1997-07-30
RU2140423C1 (ru)	1999-10-27
FR2706454B1 (fr)	1995-09-15
ZA943381B (en)	1995-05-17
KR100341427B1 (ko)	2002-11-14
HU9401427D0 (en)	1994-08-29

Legal Events

Date	Code	Title	Description
1997-09-15	UEP	Publication of translation of european patent specification
2004-03-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE150466T1 (de)	1997-04-15	Neue 19-nor-steroide mit einer 11-beta- phenoxysulfonamid- oder 11-beta- phenoxysulfonylurea-gruppe, verfahren und zwischenprodukte zu ihrer herstellung sowie medikamenten und pharmazeutische präparate davon
ATE25974T1 (de)	1987-04-15	Acyl-substituierte derivate von 1,2,3,4tetrahydroisochinolin-3-carboxysaeuren, ihre salze, diese enthaltende arzneimittel und verfahren zu ihrer herstellung.
ATE133683T1 (de)	1996-02-15	Erythromycinderivate, ihre verfahren zur herstellung, zwischenprodukte und ihre anwendung als medikamente
DE59005254D1 (de)	1994-05-11	24-Homo-Vitamin-D-Derivate, Verfahren zu ihrer Herstellung; diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung als Arzneimittel.
ZA929859B (en)	1993-12-20	19-nor steroids having a thiocarbon chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and the pharmaceutical compositions containing them
AT384424B (de)	1987-11-10	Verfahren zur herstellung von neuen 3-hydroxy-2-oxo-pyrrolidinderivaten und ihren salzen
ATE99320T1 (de)	1994-01-15	19-nor-steroide mit einem ein anoid oder carbamat enthaltenden kohlenwasserstoffrest in stellung 11-beta, verfahren zu deren herstellung, zwischenprodukte, ihre anwendung als arzneimittel und pharmazeutische zusammensetzungen, die sie enthalten.
ATE136035T1 (de)	1996-04-15	Steroidderivate, die ein substituiertes thioethylradikal an der stelle 10 des steroids tragen, verfahren zu ihrer herstellung und zwischenprodukte davon, ihre verwendung als arzneimittel und pharmazeutische präparate davon
ATE193531T1 (de)	2000-06-15	Phenyl-carboxamide-isoxazole-derivate und salze, verfahren zu ihrer herstellung ihre anwendung als arzneimittel und pharmazeutische zusammensetzungen die sie enthalten
DE69302726D1 (de)	1996-06-27	Neue Steroide mit einer an der 17-Stelle spiro-kondensierte Methylen-Laktongruppe, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und pharmazeutische Präparate davon
ATE104278T1 (de)	1994-04-15	N-substituierte alpha-mercaptoalkylaminderivate, verfahren zu ihrer herstellung und hergestellte zwischenprodukte, ihre verwendung als arzneimittel und diese enthaltende zusammensetzungen.
ATE42561T1 (de)	1989-05-15	In position 10 durch ein eine doppel- bzw. dreifachbindung enthaltendes radikal substituierte neue steroide, verfahren zu ihrer herstellung, ihre anwendung als heilmittel und diese enthaltende pharmazeutische praeparate.
DE69310052D1 (de)	1997-05-28	Kardioaktive 17B-(3-Furyl) und 17B-(4-Pyridazinyl)-5beta, 14beta-Androstan Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate davon
DE69321861D1 (de)	1998-12-10	3-Aminochroman-Spiroderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE69020632D1 (de)	1995-08-10	4-Phenylmethyl-1H-indol-Derivate, Verfahren und Zwischenverbindungen zu deren Herstellung, Anwendung als Arzneimittel und diese enthaltende Zusammensetzungen.
HUP0001773A2 (hu)	2000-11-28	Szubsztituált tetrahidropiridinszármazékok, eljárás előállításukra, továbbá a vegyületeket tartalmazó gyógyászati készítmények
DE69217613D1 (de)	1997-04-03	Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
ATE5961T1 (de)	1984-02-15	N-acylpeptid-verbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE166060T1 (de)	1998-05-15	Neue (estradiol-derivat)-chlorambucil-konjugate, verfahren zu ihrer herstellung und pharmazeutische präparate
DE69011901D1 (de)	1994-10-06	1-Arylsulfonyl-2-piperidinon-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende Zusammensetzungen.
NO903291D0 (no)	1990-07-24	Renin-hemmende aminooligohydroksy-derivater.
KR950704322A (ko)	1995-11-17	스피로푸라논 유도체 및 그의 신경변성 질환 치료 용도(Spirofuranone Derivatives and Their Use in the Treatment of Neurodegenerative Disorders)
DE3782619D1 (de)	1992-12-17	1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente.
DE59107442D1 (de)	1996-04-04	Substituierte 3-Thia- bzw. 3-Oxa-alkyl-Flavone, Verfahren zu ihrer Herstellung, Verwendung derselben, Arzneimittel auf Basis dieser Verbindungen sowie Zwischenprodukte
ATE87004T1 (de)	1993-04-15	Fluor enthaltende makrolid-verbindungen, pharmazeutische zusammensetzungen, welche diese enthalten und ihre verwendung fuer die herstellung von arzneimitteln.